@article{ACS16814,
author = {Johanna Mulzer and Hristo Krastev and Christoph Hoermandinger and Alexander Meyer and Thomas Haese and Julia Stein and Marcus Müller and Felix Schoenrath and Christoph Knosalla and Christoph Starck and Volkmar Falk and Evgenij Potapov and Jan Knierim},
title = {Development of tricuspid regurgitation and right ventricular performance after implantation of centrifugal left ventricular assist devices},
journal = {Annals of Cardiothoracic Surgery},
volume = {10},
number = {3},
year = {2021},
keywords = {},
abstract = {Background: Tricuspid regurgitation (TR) after left ventricular assist device (LVAD) implantation is associated with a poor prognosis. This study evaluates the development of TR and right ventricular (RV) performance after LVAD implantation.
Methods: Retrospective analysis of patients who underwent LVAD implantation between March 2018 and June 2019. Patients who underwent concomitant tricuspid valve surgery and patients with congenital heart disease were excluded.
Results: A total of 155 patients underwent LVAD implantation. Fourteen patients were excluded. Of the remaining patients, thirty-one died during the first six months, six were lost to follow-up and two underwent transplantation. 102 patients presented at 6.3 months (5.8 to 7.0). Patients were supported with HeartWare HVAD (74%) or HeartMate 3 (26%). 50.4% were rated as INTERMACS profile 1 or 2. At six months, systolic pulmonary artery pressure dropped from 36 to 21 mmHg (P},
issn = {2304-1021}, url = {https://www.annalscts.com/article/view/16814}
}